Cargando…

Measures to Maintain a SARS-CoV-2 Negative Inpatient Hematological Unit in the Midst of the COVID-19 Pandemic

The University Hospital of Salamanca, in Spain, had its first COVID-19 case on March 1st and as of May 11th, we had 1,100 positive cases. Based on the vulnerability of patients with blood cancers, on March 9th, the Hematology Department developed a protocol, amended as the new information was availa...

Descripción completa

Detalles Bibliográficos
Autores principales: Cabero-Martínez, Almudena, Sánchez-Guijo, Fermín, López-Corral, Lucía, Pérez, Estefanía, Avendaño, Alejandro, Baile, Mónica, Cabrero, Mónica, Martín, Ana-Africa, Rodríguez, Angela, Pérez, Balbina, Peña-Muñoz, Felipe, Román, Luz-Gema, Palomino, Danylo, López-Vázquez, Lourdes, Vidriales, María-Belén, González-Diaz, Marcos, Mateos, María-Victoria, Caballero, María-Dolores
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7479128/
https://www.ncbi.nlm.nih.gov/pubmed/32984363
http://dx.doi.org/10.3389/fmed.2020.00462
Descripción
Sumario:The University Hospital of Salamanca, in Spain, had its first COVID-19 case on March 1st and as of May 11th, we had 1,100 positive cases. Based on the vulnerability of patients with blood cancers, on March 9th, the Hematology Department developed a protocol, amended as the new information was available, to maintain the Hematology Unit as a “free COVID-19 island.” The protocol included symptom-based surveys and screening tests to patients, caregivers, and healthcare personnel to identify early potential positive cases and prevent its spread. Between March 9 and April 28, 32 asymptomatic patients and caregivers were tested and 68 rT-PCR diagnostic assays have been performed with two positive results. A 106 healthcare workers have been tested (208 rT-PCR) and seven of them were positive. In summary, the implementation of preemptive measures after the first case appeared allowed us to be able to provide treatment to our patients.